Clinical Trials on Borderline Resectable Adenocarcinoma of the Head of the Pancrease
Total 9779 results
-
GlaxoSmithKlineCompletedRotavirus Infection | Evidence of PCV-1 Replication and/or Immune Response to the PCV-1 in HRV Vaccinated Infants
-
BiogenCompletedMultiple Sclerosis, Relapsing-RemittingItaly
-
Eunice Kennedy Shriver National Institute of Child...U.S. Department of EducationWithdrawn
-
Genzyme, a Sanofi CompanyBayerCompletedMultiple Sclerosis, Relapsing-RemittingAustralia, Denmark, Canada, United States, Netherlands, Argentina, Austria, Belgium, Brazil, Croatia, Czech Republic, France, Germany, Israel, Italy, Mexico, Poland, Russian Federation, Serbia, Spain, Sweden, Ukraine, United Kingdom
-
University of South FloridaCompletedMultiple SclerosisUnited States
-
University of Illinois at Urbana-ChampaignNational Multiple Sclerosis SocietyCompleted
-
BiogenCompletedRelapsing Multiple SclerosisUnited States, Puerto Rico
-
Universita di VeronaUnknownMultiple SclerosisItaly
-
Washington University School of MedicineBiogenWithdrawnMultiple Sclerosis | Multiple Sclerosis, Relapsing-RemittingUnited States
-
Instituto Jalisciense de CancerologiaUniversity of Guadalajara; Instituto Mexicano del Seguro SocialUnknownMultiple Sclerosis, Relapsing-RemittingMexico
-
Jochen VehoffCompletedMultiple Sclerosis | Autonomic Nervous System DysfunctionSwitzerland
-
Rambam Health Care CampusUnknownMultiple Sclerosis
-
GlaxoSmithKlineCompletedMultiple Sclerosis, Relapsing-RemittingBelgium, Germany, Russian Federation, Spain, Poland
-
Rennes University HospitalUniversity Hospital, Angers; Ministry of Health, France; Central Hospital, Nancy... and other collaboratorsUnknownMultiple Sclerosis
-
University at BuffaloCharles University, Czech Republic; Biogen; Jacobs Neurological InstituteCompletedMultiple Sclerosis
-
Merck KGaA, Darmstadt, GermanyCompletedMultiple Sclerosis, Relapsing-Remitting
-
Merck KGaA, Darmstadt, GermanyGesellschaft für Therapieforschung mbHCompleted
-
EMD SeronoCompletedMultiple Sclerosis, Relapsing-Remitting
-
Merck KGaA, Darmstadt, GermanyTerminatedMultiple Sclerosis, Relapsing-RemittingDenmark
-
EMD SeronoMerck Serono International SACompletedMultiple Sclerosis, Relapsing-Remitting
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedMultiple Sclerosis, Relapsing-Remitting
-
Hospices Civils de LyonUnknownMultiple SclerosisFrance
-
Nelson Mandela Metropolitan UniversityUnknownMultiple Sclerosis, Relapsing-RemittingUnited States
-
BiogenElan PharmaceuticalsCompletedSafety and Efficacy of Natalizumab in Combination With Avonex in the Treatment of Multiple SclerosisMultiple Sclerosis, Relapsing-RemittingUnited States, Germany, Austria, Belgium, France, Israel, Italy
-
BiogenElan PharmaceuticalsCompletedMultiple Sclerosis, Relapsing-Remitting
-
University of California, San FranciscoCompletedMultiple SclerosisUnited States
-
National Center for Research Resources (NCRR)University of MarylandCompleted
-
Northwestern Memorial HospitalCompleted
-
New Mexico Cancer Care AllianceTerminatedHepatocellular Carcinoma | Bile Duct Cancer | Gallbladder Cancer | Cholangiocellular Carcinoma | Extrahepatic Bile Duct Cancer | Cholangiocarcinoma of the Extrahepatic Bile Duct | Periampullary AdenocarcinomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingGastric Adenocarcinoma | Oligometastasis | Stage IV Esophageal Cancer AJCC v7 | Stage IV Gastric Cancer AJCC v7 | Stage IV Esophageal Adenocarcinoma AJCC v7United States
-
Centre Hospitalier de GonesseNot yet recruitingQuality of Life | Multiple Sclerosis | Cognitive Dysfunction | Neuropsychological TestsFrance
-
Lille Catholic UniversityNovartis; Région Nord-Pas de Calais, France; Université de Lille; La Ligue Française...CompletedQuality of Life | Multiple Sclerosis | Physical Disability | Social Interaction | Economic Burden | Capability
-
Mei-fang HuangUnknownTo Investigate the Effectiveness of Health Management of Glycemic Control and Physical Activity in Type 2 Diabetes Mellitus Using Smartphone ApplicationTaiwan
-
Cardiff UniversityCompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter | Urethral CancerUnited Kingdom
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter | Urethral Cancer
-
Southwest Oncology GroupNational Cancer Institute (NCI)TerminatedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter | Urethral Cancer
-
Montefiore Medical CenterCompletedTransient Tachypnea of the Newborn | Respiratory Distress | Delayed Transition of the Newborn | Persistent Pulmonary HypertensionUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI); PfizerCompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter | Urethral CancerUnited States
-
Medical Research CouncilCompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter | Urethral CancerCanada, United Kingdom, Norway, New Zealand, Netherlands, South Africa, Brazil, Finland
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter | Urethral CancerUnited States
-
BioNTech SERecruitingRecurrent Head and Neck Cancer | Unresectable Head and Neck Squamous Cell Carcinoma | Metastatic Head and Neck CancerGermany, United States, France, United Kingdom, Belgium, Spain, Canada, Poland, Brazil, Taiwan, Israel, Czechia, Australia, Italy, Mexico, Argentina, Austria, Hungary, Portugal, Chile, Sweden, South Korea, Turkey (Türkiye)
-
DxTerity DiagnosticsNational Cancer Institute (NCI)CompletedCancer | Cancer of Liver | Cancer of Pancreas | Cancer of Stomach | Cancer of Cervix | Cancer of Colon | Cancer of Rectum | Cancer of Kidney and Renal Pelvis | Cancer of Prostate | Radiation Therapy | Cancer of Esophagus | Cancer of Ovary | Cancer of Kidney | Cancer of Bladder | Cancer of Gallbladder | Cancer of Anus | Cancer... and other conditionsUnited States
-
Wuhan UniversityPeking University; PfizerUnknownThe Primary Evaluation is the Change From Baseline at End of Study for CDSS Total Scores. | The Secondary Efficacy Evaluations Include: MADRS, PANSS Total Scores and Subscales and Responder Rate; CGI-S and CGI-I Scales. | Safety Evaluations Include: Laboratory Test Abnormalities; BARS... and other conditions
-
National Cancer Institute (NCI)CompletedEndometrial Carcinoma | Endometrial Atypical Hyperplasia/Endometrioid Intraepithelial Neoplasia | FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma | FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma | Atypical HyperplasiaUnited States
-
Charite University, Berlin, GermanyRecruitingMultiple Sclerosis | Fatigue in Multiple SclerosisGermany
-
Somogy Megyei Kaposi Mór Teaching HospitalRecruitingStroke | Multiple SclerosisHungary
-
Centre Hospitalier de GonesseNot yet recruitingMultiple Sclerosis | Feasibility Studies | Disease ManagementFrance
-
Xuanwu Hospital, BeijingRecruitingMultiple Sclerosis | Electric StimulationChina
-
Washington University School of MedicineRecruitingLung Cancer | Cancer of the LungUnited States